Literature DB >> 290570

Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.

H D Kay, R Fagnani, G D Bonnard.   

Abstract

When Fc receptors (FcR) on normal human peripheral blood lymphocytes were induced to modulate by overnight (18 h) incubation in the presence of soluble or particulate immune complexes, the natural killer (NK) activity of the effector lymphocyte suspension, as measured against the K562 erythroleukemia cell line, was significantly, but only partially, inhibited. The NK activity which remained was always strong, and was not significantly inhibited by inclusion of antigen-antibody complexes in the cytotoxicity assay, nor was it further depleted by adsorbing the modulated cells on plastic surfaces coated with immobilized antigen-antibody complexes. Antibody-dependent cell-mediated cytotoxicity (ADCC) against rabbit antibody-sensitized Chang liver cells was totally abrogated following the modulation process, and could not be restored by exposure of modulated effector cells to trypsin, indicating that the FcR had actually been shed and were not merely being blocked with immune complexes. Although freshly isolated peripheral blood lymphocytes active in natural (or "spontaneous") cytotoxicity have been shown to bear FcR, our data indicate that NK activity against the K562 cell line can be effectively mediated by NK cells which have lost their FcR. This supports the concept that NK activity against K562 is independent of FcR, and, therefore, of IgG.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 290570     DOI: 10.1002/ijc.2910240204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.

Authors:  M Mirić; J Vasiljević; M Bojić; Z Popović; N Keserović; M Pesić
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

2.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

3.  Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?

Authors:  K S Froebel; R Madhok; C D Forbes; S E Lennie; G D Lowe; R D Sturrock
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis.

Authors:  W Abo; J D Gray; A C Bakke; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

5.  Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.

Authors:  J I Ravdin; R L Guerrant
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  In Vivo Study of Natural Killer (NK) Cell Cytotoxicity Against Cholangiocarcinoma in a Nude Mouse Model.

Authors:  In Hye Jung; DO Hee Kim; DA Kyung Yoo; Sun Young Baek; Seong Hoon Jeong; Dawoon E Jung; Seung Woo Park; Yong-Yoon Chung
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

7.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

8.  The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.

Authors:  Amanda B Macedo; Callie Levinger; Bryan N Nguyen; Jonathan Richard; Mamta Gupta; Conrad Russell Y Cruz; Andrés Finzi; Katherine B Chiappinelli; Keith A Crandall; Alberto Bosque
Journal:  J Virol       Date:  2022-07-14       Impact factor: 6.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.